Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

NC HEALTHCARE (1518.HK)

Compare
1.200
-0.030
(-2.44%)
At close: April 3 at 1:22:54 PM GMT+8
Loading Chart for 1518.HK
  • Previous Close 1.230
  • Open 1.200
  • Bid 1.150 x --
  • Ask 1.300 x --
  • Day's Range 1.200 - 1.200
  • 52 Week Range 0.650 - 1.400
  • Volume 16,500
  • Avg. Volume 155,516
  • Market Cap (intraday) 585.541M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 6.67
  • EPS (TTM) 0.180
  • Earnings Date Mar 27, 2025
  • Forward Dividend & Yield 0.02 (1.84%)
  • Ex-Dividend Date May 29, 2025
  • 1y Target Est --

New Century Healthcare Holding Co. Limited, an investment holding company, provides healthcare services to women and children in the People's Republic of China. The company offers paediatric, obstetric, and gynaecologic services; and hospital consulting services. It also provides online healthcare services, as well as operates cafeteria and gift shop at its medical institutions. The company was founded in 2002 and is headquartered in Beijing, the People's Republic of China.

www.ncich.com.cn

1,255

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1518.HK

View More

Performance Overview: 1518.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1518.HK
20.00%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

1518.HK
40.96%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

1518.HK
18.14%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

1518.HK
23.90%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 1518.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1518.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    585.54M

  • Enterprise Value

    438.35M

  • Trailing P/E

    6.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    1.03

  • Enterprise Value/Revenue

    0.44

  • Enterprise Value/EBITDA

    2.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.60%

  • Return on Assets (ttm)

    9.47%

  • Return on Equity (ttm)

    19.52%

  • Revenue (ttm)

    846.5M

  • Net Income Avi to Common (ttm)

    47.38M

  • Diluted EPS (ttm)

    0.180

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    354.52M

  • Total Debt/Equity (mrq)

    36.52%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1518.HK

View More

Company Insights: 1518.HK

Research Reports: 1518.HK

View More

People Also Watch